ROSUVASTATIN FOR REDUCTION OF MYOCARDIAL DAMAGE DURING CORONARY INTERVENTION
Ahmed Abd EI-Azim Mohamed Kenawy;
Abstract
The incidence of elevated biomarkers of myocardial damage after percutaneous coronary intervention (PCI) is 1-30%. This variation reflects differences in the biomarker measured and the patient population being treated. There is an increasing consensus tha
Other data
| Title | ROSUVASTATIN FOR REDUCTION OF MYOCARDIAL DAMAGE DURING CORONARY INTERVENTION | Other Titles | تأثير عقار روزيوفاستاتين للحد من نسبة حدوث تلف عضلة القلب أثناء القسطرة التداخلية للشرايين التاجية | Authors | Ahmed Abd EI-Azim Mohamed Kenawy | Keywords | ROSUVASTATIN FOR REDUCTION OF MYOCARDIAL DAMAGE DURING CORONARY INTERVENTION | Issue Date | 2014 | Description | The incidence of elevated biomarkers of myocardial damage after percutaneous coronary intervention (PCI) is 1-30%. This variation reflects differences in the biomarker measured and the patient population being treated. There is an increasing consensus tha |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 123615R9493.pdf | 189.09 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.